刊名：中国实验血液学杂志
曾用名：实验血液学杂志
主办：中国病理生理学会
主管：中国科学技术协会
ISSN：1009-2137
CN：11-4423/R
语言：中文
周期：双月刊
影响因子：0.610899984836578
被引频次：34668
数据库收录：
北大核心期刊（2011版）;北大核心期刊（2014版）;化学文摘（网络版）;生物医学检索系统;文摘与引文数据库;中国科技核心期刊;期刊分类：临床医学
期刊热词：
白血病,多发性骨髓瘤,急性髓系白血病,细胞凋亡,骨髓增生异常综合征,急性白血病,K562细胞,间充质干细胞,急性淋巴细胞白血病,造血干细胞移植,
现在的位置：主页 > 综合新闻 >
聂广:关于中药砒霜和雄黄的现代故事(6)
【作者】网站采编【关键词】【摘要】46. Wang ZY，Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood. 2008 Mar 1;111(5):2505-15. 47. Chen GQ，Zhou L，Styblo M，Walton F，Jing Y，Weinberg R，Chen Z，W
46. Wang ZY，Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood. 2008 Mar 1;111(5):2505-15.
47. Chen GQ，Zhou L，Styblo M，Walton F，Jing Y，Weinberg R，Chen Z，Waxman S. Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells. Cancer Res. 2003 Apr 15;63(8):1853-9.
48. Wang K，Wang P，Shi J，Zhu X，He M，Jia X，Yang X，Qiu F，Jin W，Qian M，Fang H， Mi J，Yang X，Xiao H，Minden M，Du Y，Chen Z，Zhang J. PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia. Cancer Cell. 2010 Feb 17;17(2):186-97.
49. Song MG， Gao SM， Du KM， Xu M， Yu Y， Zhou YH， Wang Q， Chen Z， Zhu YS， Chen GQ. Nanomolar concentration of NSC， a camptothecin analog， induces leukemic-cell apoptosis through protein kinase Cdelta-dependent mechanisms. Blood. 2005 May 1;105(9):3714-21.
50. Du Y，Wang K，Fang H，Li J，Xiao D，Zheng P，Chen Y，Fan H，Pan X，Zhao C，Zhang Q，Imbeaud S，Graudens E，Eveno E，Auffray C，Chen S，Chen Z，Zhang J. Coordination of intrinsic， extrinsic， and endoplasmic reticulum-mediated apoptosis by imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia. Blood. 2006 Feb 15;107(4):1582-90.
51. Zhao KW，Li X，Zhao Q，Huang Y，Li D，Peng ZG，Shen WZ，Zhao J，Zhou Q，Chen Z， Sims PJ，Wiedmer T，Chen GQ. Protein kinase Cdelta mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation. Blood. 2004 Dec 1;104(12):3731-8.
52. Xiao DK，Du YZ，Fan HY，Chen YL，Chen Z，Zhang J，Wang KK. Mechanisms of fenretinide-triggered apoptosis in leukemic cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):975-8. Chinese.
53. Meng X，Cheng G，Cao W，Zhu J，Chen J，Chen Z，Chen S. Development of Acute Promyelocytic Leukemia in PML-RARalpha Transgenic Mice. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2000 Jun;8(2):104-109. Chinese.
54. e Thé H，Chen Z. Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev Cancer. 2010 Nov;10(11):775-83.
55. Chen SJ，Zhou GB. Targeted therapy: The new lease on life for acute promyelocytic leukemia， and beyond. IUBMB Life. 2012 Aug;64(8):671-5.
57. Yang HT，Wu DH，Xue XY，Liang WX，Miao XY，Pang H，Chen SJ. Cloning，expression， purification and crystallization of NHR3 domain from acute myelogenous leukemia-related protein AML1-ETO. Acta Biochim Biophys Sin (Shanghai). 2004 Aug;36(8):566-70.
58. Chen SJ，Chen LJ，Zhou GB. Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):1-8. Chinese.
59. Zhen T，Chen SJ. Progress on targeted therapy of acute myeloid leukemia with active components of Chinese herbal medicines. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Jan;29(1):14-8. Chinese.
60. Shi L，Wang YY，Chen SJ. Recent progress of study on retroviral mediated mouse model of myeloid leukemia --review. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Aug;19(4):1058-63.
61. Shi WY，Wang L，Xiao D，Yao Y，Yang F，Jiang XX，Leboeuf C，Janin A，Chen SJ，Zhao WL. Proteasome inhibitor bortezomib targeted tumor-endothelial cell interaction in T-cell leukemia/lymphoma. Ann Hematol. 2011 Jan;90(1):53-8.
62. Wang QR，Shi JY，Shi L，Chen SJ. Mutational detection of full-length mixed lineage leukemia gene in patients with de novo AML-M4 and M5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Feb;20(1):12-7
63. Wang L，Shi WY，Yang F，Tang W，Gapihan G，Varna M，Shen ZX，Chen SJ，Leboeuf C， Janin A，Zhao WL. Bevacizumab potentiates chemotherapeutic effect on T-leukemia/lymphoma cells by direct action on tumor endothelial cells. Haematologica. 2011 Jun;96(6):927-31.
64. Wang Y，Gu MM，Tan Y，Lu SY，Wang L，Kong H，Sun YP，Lu ZY，Chen SJ，Wang ZY， Wang ZG. Development of human myeloid leukemia-like phenotype in NUP98-PMX1 transgenic mice. Zhonghua Xue Ye Xue Za Zhi. 2004 May;25(5):262-5. Chinese
65. Chen SJ. Mutation associations in RA-defiant APL. Blood. 2012 Sep 6;120(10):1969-70.
66. Dong S，Chen SJ，Tweardy DJ. Cross-talk between retinoic acid and STAT3 signaling pathways in acute promyelocytic leukemia. Leuk Lymphoma. 2003 Dec;44(12):2023-9. Review.
67. Chen SJ，Zhou GB. Targeted therapy: The new lease on life for acute promyelocytic leukemia，and beyond. IUBMB Life. 2012 Aug;64(8):671-5.
68. Zhen T，Chen SJ. Progress on targeted therapy of acute myeloid leukemia with active components of Chinese herbal medicines. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Jan;29(1):14-8. Chinese.
文章来源：《中国实验血液学杂志》 网址: http://www.zgsyxyxzz.cn/zonghexinwen/2020/0909/426.html
上一篇：重磅！2020未来科学大奖公布，4位学者获奖
下一篇：细胞免疫治疗背后的绝症女孩儿
中国实验血液学杂志投稿 | 中国实验血液学杂志编辑部| 中国实验血液学杂志版面费 | 中国实验血液学杂志论文发表 | 中国实验血液学杂志最新目录
Copyright © 2018 《中国实验血液学杂志》杂志社 版权所有
投稿电话： 投稿邮箱：